BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 19937791)

  • 1. Percutaneous management of a Fontan fenestration: in search for the ideal restriction-occlusion device.
    Boshoff DE; Brown SC; Degiovanni J; Stumper O; Wright J; Mertens L; Gewillig M
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):60-5. PubMed ID: 19937791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occlusion of Fontan fenestrations using Amplatzer septal occluder.
    Al-Hay AA; Abushaban L; Al-Qbandi MA; Alanbaei M
    Int J Cardiovasc Imaging; 2011 Apr; 27(4):483-90. PubMed ID: 20859688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fontan fenestration closure with Amplatzer Duct Occluder II device.
    McCrossan BA; Walsh KP
    Catheter Cardiovasc Interv; 2015 Apr; 85(5):837-41. PubMed ID: 25504151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility and clinical impact of transcatheter closure of interatrial communications after a fenestrated Fontan procedure: medium-term outcomes.
    Pihkala J; Yazaki S; Mehta R; Lee KJ; Chaturvedi R; McCrindle BW; Van Arsdell G; Benson LN
    Catheter Cardiovasc Interv; 2007 Jun; 69(7):1007-14. PubMed ID: 17421018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous management of cyanosis in Fontan patients using Amplatzer occluders.
    Masura J; Bordacova L; Tittel P; Berden P; Podnar T
    Catheter Cardiovasc Interv; 2008 May; 71(6):843-9. PubMed ID: 18412082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a new low profile Occlutech PLD device for closure of Fontan fenestrations.
    De Wolf D; Dessy H; Haas N
    Catheter Cardiovasc Interv; 2016 May; 87(6):E243-7. PubMed ID: 26526601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein-losing enteropathy resolved by percutaneous intervention.
    Butera G; Marini D; MacDonald ST
    Catheter Cardiovasc Interv; 2011 Oct; 78(4):584-8. PubMed ID: 21805565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcatheter closure of fenestrations and excluded hepatic veins after fontan: versatility of the Amplatzer device.
    Moore JW; Murdison KA; Baffa GM; Kashow K; Murphy JD
    Am Heart J; 2000 Sep; 140(3):534-40. PubMed ID: 10966558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interventional occlusion of interatrial communication after modified Fontan operation].
    Gamillscheg A; Beitzke A; Stein JI; Zobel G; Rödl S; Zartner P
    Z Kardiol; 2002 Apr; 91(4):304-11. PubMed ID: 12063702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creation of a transcatheter fenestration in children with failure of Fontan circulation: Focus on extracardiac conduit connection.
    Rupp S; Schieke C; Kerst G; Mazhari N; Moysich A; Latus H; Michel-Behnke I; Akintuerk H; Schranz D
    Catheter Cardiovasc Interv; 2015 Dec; 86(7):1189-94. PubMed ID: 26119855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new Amplatzer device to maintain patency of Fontan fenestrations and atrial septal defects.
    Amin Z; Danford DA; Pedra CA
    Catheter Cardiovasc Interv; 2002 Oct; 57(2):246-51. PubMed ID: 12357531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracardiac Fontan Fenestration Device Closure with Amplatzer Vascular Plug II and Septal Occluder: Procedure Results and Medium-Term Follow-Up.
    Webb MK; Hunter LE; Kremer TR; Huddleston CB; Fiore AC; Danon S
    Pediatr Cardiol; 2020 Apr; 41(4):703-708. PubMed ID: 31894396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Device occlusion of Fontan fenestration--an economical alternative.
    Prem Sekar R; Cherian KM
    Asian Cardiovasc Thorac Ann; 2007 Oct; 15(5):e55-7. PubMed ID: 17911056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Safety and efficacy of transcatheter closure of Fontan fenestration with atrial septal occluder].
    Guo Y; Liu TL; Xu XY; Gao W
    Zhonghua Xin Xue Guan Bing Za Zhi; 2023 May; 51(5):476-480. PubMed ID: 37198118
    [No Abstract]   [Full Text] [Related]  

  • 15. Transcatheter closure of extracardiac fontan fenestration in a cyanotic patient.
    Demir F; Karagöz T; Aypar E; Atalay S; Tutar E
    Turk J Pediatr; 2010; 52(4):439-42. PubMed ID: 21043396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter coil occlusion of surgical fenestration after Fontan operation.
    Sommer RJ; Recto M; Golinko RJ; Griepp RB
    Circulation; 1996 Aug; 94(3):249-52. PubMed ID: 8759062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Closure of extrocardiac Fontan fenestration by using the Amplatzer duct occluder].
    Boudjemline Y; Bonnet D; Sidi D; Agnoletti G
    Arch Mal Coeur Vaiss; 2005 May; 98(5):449-54. PubMed ID: 15966592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shunt reduction with a fenestrated Amplatzer device.
    Kretschmar O; Sglimbea A; Corti R; Knirsch W
    Catheter Cardiovasc Interv; 2010 Oct; 76(4):564-71. PubMed ID: 20882662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occlusion of Fontan fenestrations using the Amplatzer septal occluder.
    Tofeig M; Walsh KP; Chan C; Ladusans E; Gladman G; Arnold R
    Heart; 1998 Apr; 79(4):368-70. PubMed ID: 9616344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel technique to reduce the size of a Fontan Diabolo stent fenestration.
    Anderson B; Bhole V; Desai T; Mehta C; Stumper O
    Catheter Cardiovasc Interv; 2010 Nov; 76(6):860-4. PubMed ID: 21053264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.